HIV (Human Immuno Virus) is one of the deadliest infections affecting close to 36.9 million people globally, with over 2.1 million reported cases in India alone. While no cure for the viral disease has been found till date, in what may be termed promising news, human trials may soon start, with a vaccine developed by a group of Chinese scientists receiving a green signal. According to confirmed reports, scientists from China will soon start testing an HIV vaccine on 160 human volunteers. The vaccine is guaranteed to have long-lasting effects to fight the infection.
This is the first time a vaccine like this has reached a second-phase human trial. The research group has already seen hundreds of volunteers registering and prep for the same has been initialized in two Chinese hospitals. The vaccine, termed DNA-rTV has been developed to boost the body's immunity, relying on the replication…
